Produktsname: | N-[1-[[1-[[1-[[1-[[2-[[1-[[1-[2-[(2-amino-2-oxoethyl)carbamoyl] pyrrolidin-1-yl]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-4- methyl-1-oxopentan-2-yl]amino]-2-oxoethyl]amino]-3-(4-hydroxyphenyl)-1- oxopropan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-3-(1H-indol-3- yl)-1-oxopropan-2-yl]amino]-3-(1H-imidazol-5-yl)-1-oxopropan-2-yl]-5- oxopyrrolidine-2-carboxamide |
CAS Registry Number: | 9034-40-6 |
EINECS: | 232-895-0 |
Synonyme: |
N-[1-[[1-[[1-[[1-[[2-[[1-[[1-[2-[(2-amino-2-oxoethyl)carbamoyl] pyrrolidin-1-yl]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-4- methyl-1-oxopentan-2-yl]amino]-2-oxoethyl]amino]-3-(4-hydroxyphenyl)-1- oxopropan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-3-(1H-indol-3- yl)-1-oxopropan-2-yl]amino]-3-(1H-imidazol-5-yl)-1-oxopropan-2-yl]-5- oxopyrrolidine-2-carboxamide; Hypocrine; Lutamin; Luforan; Fertagyl; Factrel; Lutal; Relefact; GONADORELIN;Dirigestran; Lutrefact; |
Molecular Structure: | |
Molecular Formula: | C55H75N17O13 |
Molecular Weight: | 1182.2901 |
Dichte: | 1.54 g/cm3 |
Flash Point: | |
S-Sätze: | An experimental teratogen. Human reproductive effects in women by subcutaneous route: menstrual cycle changes and other unspecified effects. Experimental reproductive effects. Used in the treatment of oligospermia and male infertility. See also LUTEINIZING HORMONE and LUTEINIZING HORMONE-RELEASING HORMONE, DIACETATE (SALT); LUTEINIZING HORMONE-RELEASING HORMONE, DIACETATE, TETRAHYDRATE; LUTEINIZING HORMONE-RELEASING HORMONE (PIG), 6-(O-(1,1-DIMETHYLETHYL)-d-SERINE)-9-(N-ETHYL-l-PROLINAMIDE)-10-DEGLYCINAMIDE-. |